Inclusion cells, seen in I-cell disease when lysosomal proteins are incorrectly targeted and build up as inclusion bodies
Parkinson's disease | Alzheimer's disease | Centers for Disease Control and Prevention | Cell nucleus | Huntington's disease | Centers for Disease Control | Bright's disease | Soft Cell | Dutch elm disease | Cell biology | Cell | disease | Crohn's disease | Chagas disease | cell | cell (biology) | B-cell activating factor | sexually transmitted disease | Plague (disease) | Chronic obstructive pulmonary disease | Cell (journal) | Cell (biology) | T cell | Sexually transmitted disease | Lyme disease | cell membrane | Mesenchymal stem cell | Gaucher's disease | Cell membrane | cardiovascular disease |
In vivo hemolysis can be caused by a large number of medical conditions, including many Gram-positive bacteria (e.g., Streptococcus, Enterococcus, and Staphylococcus), some parasites (e.g., Plasmodium), some autoimmune disorders (e.g., drug-induced hemolytic anemia), some genetic disorders (e.g., Sickle-cell disease or G6PD deficiency), or blood with too low a solute concentration (hypotonic to cells).
For example, in November 2010, Dr. Jeffery K. Taubenberger of the National Institutes of Health discovered the earliest proof of Sickle-cell disease while looking for the virus of the 1918 flu during the autopsy of an African-American soldier.